Protagonist Therapeutics Inc (PTGX)

Operating return on assets (Operating ROA)

Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019
Operating income (ttm) US$ in thousands 148,678 -93,652 -153,217 -147,194 -146,283 -131,373 -131,873 -133,496 -122,935 -125,845 -107,659 -81,505 -68,840 -64,516 -62,985 -72,380 -85,570 -80,521 -78,634 -70,856
Total assets US$ in thousands 629,276 357,951 330,016 320,466 239,858 247,928 282,174 310,512 348,296 347,695 373,175 404,232 298,072 324,468 217,320 224,980 134,901 154,917 154,627 148,105
Operating ROA 23.63% -26.16% -46.43% -45.93% -60.99% -52.99% -46.73% -42.99% -35.30% -36.19% -28.85% -20.16% -23.10% -19.88% -28.98% -32.17% -63.43% -51.98% -50.85% -47.84%

March 31, 2024 calculation

Operating ROA = Operating income (ttm) ÷ Total assets
= $148,678K ÷ $629,276K
= 23.63%

Protagonist Therapeutics Inc's operating return on assets (operating ROA) has shown significant fluctuations over the past several quarters. The data reveals that the company's operating ROA has ranged from -63.43% to 23.63% during the period under review.

The operating ROA was consistently negative from December 2019 to March 2024, with the lowest point recorded in March 2020 at -63.43%. This suggests that during these periods, the company's operating income generated from its assets was insufficient to cover the cost of those assets.

However, there was a notable improvement in the operating ROA in March 2024, reaching 23.63%, indicating a positive trend in the company's ability to generate operating income from its assets.

Overall, Protagonist Therapeutics Inc's operating ROA performance has been volatile, with periods of both negative and positive returns. The company may need to focus on improving operational efficiency and asset utilization to drive sustainable profitability in the future.


Peer comparison

Mar 31, 2024